Phase 1/2 Studies

Identify biomarkers of response and resistance to guide your Phase 3 strategy

Biomarkers of response

Identify baseline and early on-treatment biomarkers of response and resistance

Timing and dosing

Optimize your timing and dosing strategy at the cellular level by profiling immune activation at critical timepoints

Patient selection

Refine patient selection for future trials by enrolling patients based on their unique immune fingerprint

Get the most out of your Phase 1/2 data

Immune profiling can increase success of Phase 1/2 to Phase 3 transition by offering valuable cellular insights into patient response

Identify immune biomarkers of response in peripheral blood

Profile major and minor immune cell subsets across cell states of activation, exhaustion, and senescence all in a single panel. Never miss a crucial cell subset again.

Optimize clinical dosing strategies

Immune monitoring can increase dosing accuracy by measuring immune activation at the cellular level. Optimize timing and dosing strategies via longitudinal blood-based monitoring to maximize and sustain treatment response.

Let data drive your patient selection

Enroll patients based on their unique immune fingerprint. Baseline biomarkers of response can refine patient selection for future trials and route patients to successful therapies.